Hyderabad Has Maximum USFDA Approved Pharma Units In World

HYDERABAD, (IANS) – Hyderabad, which has emerged as a key global hub in life sciences, is home to the largest number of US Food and Drug Administration (USFDA) approved companies in the world.

With 214 units certified by the US drug administrator, Hyderabad is far ahead of New Jersey, which stands second with 189 USFDA-approved units, Telangana Industries, Commerce, and Information Technology Minister K.T. Rama Rao said on February 21. He said the state government would make efforts for setting up of USFDA office in Hyderabad.

He also said the Telangana government has set the ambitious goal of doubling the size of the life sciences sector to $100 billion by 2028. It is also looking at increasing the workforce to 8 lakhs from the current 4 lakh employees.

The 20th edition of Bio Asia, beginning on February 24, is expected to give further impetus to the state’s efforts to strengthen the life sciences sector.

Currently, 9 billion doses of vaccines are made in Hyderabad annually and next year, this is likely to go up to 14 billion. At present, Hyderabad accounts for 35 percent of the global vaccine production, and next year the city’s contribution is expected to increase to 50 percent.

Hyderabad also accounts for 40 percent of India’s pharmaceutical production.

The Medical Devices Park near Hyderabad has run out of space. This is the largest medical devices park in the world. A Hyderabad Pharma City is coming up on 14,000 acres of land will be the world’s largest pharma cluster.

In Genome Valley, the mega cluster for life sciences R&D, 30 lakh square feet of lab space has already been taken by the companies while another 20 lakh square feet of space is being developed. Genome Valley is home to more than 200 companies including marquee global names like Novartis, GlaxoSmithKline, Ferring Pharma, Chemo, DuPont, Ashland, United States Pharmacopeia, and Lonza.